Teiko Bio
PrivateLast Round
Series A
Dec 20, 2021
Total Funding Raised
$11.6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Teiko Bio operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Series A round in December 2021.
Teiko Bio is a biotechnology company that provides a precision immune monitoring platform and contract research organization services for clinical trials and diagnostics development.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teiko Bio Comparables
Compare Teiko Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IMU Biosciences | 85% | |
| Sirona Dx | 81% | |
| CellCarta | 73% |
For institutional investors. Book with your work email.
Teiko Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 20, 2021 | ||||
| Seed | Jul 5, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Teiko Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Founders Capital | Series A |
| Alix Ventures | Series A |
| EPIC Ventures | Series A |
| Tau Ventures | Seed |
| Altitude Lab | Seed |
| HOF Capital | Series A |
| Civilization Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 19, 2026
Grew 19% QoQ, from 21 to 25 employees.
- Sep 12, 2026
Monthly visitors grew 57% MoM, from 9.1K to 14.2K.
For institutional investors. Book with your work email.
Teiko Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Teiko Bio's valuation, stock price, and market status.
Is Teiko Bio a public or private company?
Teiko Bio is a private company.
What is the current stock price of Teiko Bio?
Teiko Bio is a private company, so its shares have no public market price. Caplight tracks Teiko Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Teiko Bio worth (valuation)?
Valuation information for Teiko Bio is not publicly available.
Can I buy Teiko Bio stock?
Teiko Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Teiko Bio's last funding round?
Teiko Bio's most recent funding round was Series A on December 20, 2021.
Who are the main investors in Teiko Bio?
Key investors in Teiko Bio include HOF Capital.
Will Teiko Bio IPO soon?
No public IPO plans have been announced for Teiko Bio.
How can I track Teiko Bio secondary market activity?
Caplight tracks bids, offers, and trades in Teiko Bio's shares on secondary markets.